NIH budget cuts target wasteful "indirect" fees, where, for example, 40% of a $3 million grant goes toward administrative costs, not research. These opaque costs fuel bureaucratic bloat. Capping or eliminating indirect rates ensures taxpayer funds prioritize science, not overhead. Private grants also show research thrives without excessive fees, forcing transparency and accountability in university spending.
Cutting funding for more than 1,300 research grants clearly threatens U.S. medical leadership, as vital studies on Alzheimer's, cancer, and brain tumors now face termination. The subsequent delays will disrupt 1,000+ projects, forcing layoffs and stalling life-saving experiments. These cuts, which also bypass Congressional approval, risk long-term damage, driving scientists away and undermining health progress for all.